Definitive Contract HHSD200201794517C
Award Date 9/29/17
Potential Completion Date 9/28/22
Potential Value $1.2M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, NJ 07940, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, for a Hepatitis C Prevalence Study. The $1,992,000.00 contract is to conduct a cross-sectional, multi-state assessment of viral hepatitis C prevalence through commercial laboratory testing of stored serum specimens, with a period of performance from September 2023 to September 2024. Quest Diagnostics has provided...
- The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
- Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a definitive firm fixed-price contract to Quest Diagnostics Incorporated for COVID-19 genomic sequencing services, with a ceiling value of $27.1 million and an ultimate completion date of April 22, 2025. The contract was awarded on May 16, 2022, and includes a termination for convenience agreement aligned with the President's DOGE cost efficiency initiative. Work will be performed at Quest Diagnostics' facility in...
- The Centers for Disease Control and Prevention (CDC) awarded a $16,500 purchase order to Quest Diagnostics Incorporated for deidentified Quest serum aliquots. Quest Diagnostics will deliver the aliquots to the CDC location in Halethorpe, Maryland by September 28, 2023 under the firm fixed price contract that began on September 1, 2023. As one of the largest clinical laboratories and medical testing companies in the United States, Quest Diagnostics will utilize its extensive experience and...
- This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
- The Centers for Disease Control and Prevention (CDC) awarded a $8,587,890.00 firm fixed price definitive contract to Quest Diagnostics Nichols Institute, doing business as Quest Diagnostics, for genomic sequencing services. The contract supports the CDC's disease prevention and health promotion efforts through genomic surveillance of viruses like COVID-19. This contract does not have a set-aside designation. Quest Diagnostics Nichols Institute, a subsidiary of the parent company Quest...
- This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Quest Diagnostics Incorporated, a provider of diagnostic information services, for a "Test Surge and Data Sharing" program. The $493,118 contract has a period of performance through September 2025 and is a time and materials type contract. This IDIQ vehicle allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...